Although somatic mutations such as the translocation or loss of heterozygosity of CBP and p300 have been observed in leukaemia as well as in solid tumours such as hepatocellular carcinoma, breast cancer and CRC, genetic mutations in these two genes remain rare [27–33]. This evidence concerns the gene CREBBP and colorectal carcinoma.